Search Results

1 - 10 of 154 items :

Clear All

References 1. Yuan S, Liao Z, Huang H, Jiang B, Zhang X, Wang Y, Zhao M Comparison of the Indicators of Psychological Stress in the Population of Hubei Province and Non-Endemic Provinces in China During Two Weeks During the Coronavirus Disease 2019 (COVID-19) Outbreak in February 2020.-Med Sci Monit. 2020 Apr 15;26:e923767. doi: 10.12659/MSM.923767. 2. Huang Y, Zhao N.-Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?-Psychol Health Med. 2020 Apr 14:1-12. doi: 10.1080/13548506.2020.1754438. [Epub

REFERENCES 1. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol . 2020;75:2352-2371. 2. Guarner J. Three Emerging Coronaviruses in Two Decades. Am J Clin Pathol . 2020;153:420-421. 3. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. J Clin Med . 2020;9:1417. 4. Giannis D

species, while gamma- and deltacoronaviruses infect bird species, although some of them may also infect mammals ( e.g . the beluga whale and pig). Over the past 17 years, there have been three epidemics in humans caused by betacoronaviruses: SARS (severe acute respiratory syndrome), MERS (Middle-East respiratory syndrome) and COVID-19 (coronavirus disease 2019). The SARS and COVID-19 outbreaks were caused by SARS-CoV-1 and SARS-CoV-2 of the subgenus Sarbecovirus while MERS had its aetiology in CoVs from the subgenus Merbecovirus . The SARS epidemic took place in 2002

INTRODUCTION Since December 2019, a new strain of the coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has appeared in Wuhan, Hubei Province, China. The disease caused by SARS-CoV-2 was officially named “COVID-19” by the World Health Organization on February 11, 2020. COVID-19 has become a pandemic, which spread across the world including more than 211 countries or regions and infected 1,914,916 patients globally (83,747 in China) by April 15, 2020. [ 1 ] SARS-CoV-2, which has a typical genome structure of CoV, belongs to the

References 1. Phelan A, Katz R, Gostin L. The novel coronavirus originating in Wuhan, China: challenges for global health governance. Jama 2020;323:709-710. 2. World Health Organization. Novel coronavirus (2019-nCoV) situation report-51. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 . March 11, 2020 3. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet

INTRODUCTION Coronavirus disease 2019 (COVID-19) is a communicable disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the Coronaviridae family, which also includes severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus(MERS-CoV). [ 1 ] It emerged in Huanan Seafood Wholesale Market in Wuhan, China, in December 2019 and continues to spread around the world. As of June 8, 2020, COVID-19 has been confirmed in 6,931,000 people worldwide. [ 2 ] People are generally

2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-13. 18. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020. 19. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62. 20. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020. 21. Metlay JP

REFERENCES 1. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;cvaa106. doi: 10.1093/cvr/cvaa106. 2. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Available at: https://www.escardio.org/Education/COVID-19-and-Cardiology/ESC-COVID-19-Guidance . 3. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314

References Almeida F. (2020). Viagem ao futuro pós-pandemia: o “novo normal” em 30 pontos Retrieved from https://executivedigest.sapo.pt/viagem-ao-futuro-pos-pandemiao-novo-normal-em-30-pontos/ . Aníbal S. (2020). Portugal perante o desafio de executar quase 6000 milhões de fundos ao ano. Retrieved from https://www.publico.pt/2020/07/21/economia/noticia/portugal-desafio-executarquase-6000-milhoes-fundos-ano-1925382 As assessed on August 11th 2020. APOPartner (2020). Modelo de Plano de Contingência (COVID-19) para Empresas. Retrieved from https

6. References Ahmed, S. Y., (2020), Impact of COVID-19 on Performance of Pakistan Stock Exchange, MPRA Paper 101540, University Library of Munich, Germany. Cepoi, C.O. (2020), Finance Research Letters, https://doi.org/10.1016/j.frl.2020.101658 Contessi, S., De Pace, P., (2020), The International Spread of COVID-19 Stock Market Collapses, Pomona Economics. 9. Daube, C. H„ (2020), The Corona Virus Stock Exchange Crash, ZBW - Leibniz Information Centre for Economics, Kiel, Hamburg Fernandes, N., (2020), Economic Effects of Coronavirus Outbreak (COVID-19) on